Clinical Trials Directory

Trials / Completed

CompletedNCT01294891

Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease

Status
Completed
Phase
Study type
Observational
Enrollment
6 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine how abnormal blood flow in the small vessels (microvessels) of the heart, muscle and kidney in paroxysmal nocturnal hemoglobinuria (PNH) or sickle cell disease leads to poor functioning of the heart and kidney. To test this question, the investigators will perform imaging tests (contrast ultrasound perfusion imaging) to look at the flow and function of these microvessels and compare this information to heart and kidney function. To further look at this question, patients who have PNH will be studied before and after starting a new drug (Soliris) that decreases damage to blood cells. In patients with sickle cell disease, patients will be studied at baseline (not during a pain crisis) and also during a pain crisis if one develops.

Conditions

Interventions

TypeNameDescription
OTHERImagingContrast ultrasound perfusion imaging and complete echocardiography

Timeline

Start date
2011-02-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2011-02-14
Last updated
2014-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01294891. Inclusion in this directory is not an endorsement.